Richard D. Francis, Officer, PRESIDENT AND CEO: Teva Pharmaceutical Industries TEVA Planned sale · Filed 25/02/18

Trade details

Type: Planned sale notice
Stock: Teva Pharmaceutical Industries TEVA
Person: Richard D. FrancisOfficer, PRESIDENT AND CEO
Planned sale date: 25/02/18
Filed: 25/02/18

$1.3M to be sold

Teva Pharmaceutical Industries trades, last 26 weeks

What else happened in Teva Pharmaceutical Industries around then

Filed or reported within 30 days of the trade day · 25/01/19~25/03/20

Richard D. Francis's recent trades

Richard D. FrancisPresident and CEO
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$211.4K
6,153 sh
$211.4K
Filed 06/08
Traded 06/05
Richard D. FrancisPresident and CEO
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$211.4K
6,153 sh
$211.4K
Filed 06/05
Traded 06/05
Richard D. FrancisPresident and CEO
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$634.2K
20,025 sh
$634.2K
Filed 03/09
Traded 03/05
Richard D. FrancisPresident and CEO
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$759.3K
23,393 sh
$759.3K
Filed 03/06
Traded 03/04
Richard D. FrancisPresident and CEO
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$634.2K
20,025 sh
$634.2K
Filed 03/05
Traded 03/05